Birdwatch Note
2023-04-12 20:10:26 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Esta noticia al afirmar que llega la vacuna contra el cáncer da lugar a una falsa realidad. Ya que primero no existe un solo tipo de tumor, y son muy diferentes en su respuesta a los tratamientos. Por otro lado se hablan de estudios preliminares en fase inicial. https://www.cancer.org/es/tratamiento/tratamientos-y-efectos-secundarios/tipos-de-tratamiento/inmunoterapia/vacunas-contra-el-cancer.html
Written by 02A82AF6133D2CB752FD7ECC10C8EDFB0F38BBD05560EBD4186CD4C40F0F0EA5
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1646108789131583489
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1646244406268141571
- noteId - 1646244406268141571
- participantId -
- noteAuthorParticipantId - 02A82AF6133D2CB752FD7ECC10C8EDFB0F38BBD05560EBD4186CD4C40F0F0EA5 Participant Details
- createdAtMillis - 1681330226856
- tweetId - 1646108789131583489
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Esta noticia al afirmar que llega la vacuna contra el cáncer da lugar a una falsa realidad. Ya que primero no existe un solo tipo de tumor, y son muy diferentes en su respuesta a los tratamientos. Por otro lado se hablan de estudios preliminares en fase inicial. https://www.cancer.org/es/tratamiento/tratamientos-y-efectos-secundarios/tipos-de-tratamiento/inmunoterapia/vacunas-contra-el-cancer.html
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-04-12 20:10:26 UTC (1681330226856) |
1969-12-31 23:59:59 UTC (-1) |
2023-04-14 02:10:59 UTC (1681438259334) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-04-13 17:42:52 -0500 | Rating Details | |
2023-04-13 14:58:52 -0500 | Rating Details | |
2023-04-13 13:20:17 -0500 | Rating Details | |
2023-04-13 13:13:53 -0500 | Rating Details | |
2023-04-13 10:59:02 -0500 | Rating Details | |
2023-04-13 09:54:59 -0500 | Rating Details | |
2023-04-13 09:49:21 -0500 | Rating Details | |
2023-04-13 04:25:35 -0500 | Rating Details | |
2023-04-13 03:51:45 -0500 | Rating Details | |
2023-04-13 02:31:36 -0500 | Rating Details | |
2023-04-13 01:21:49 -0500 | Rating Details | |
2023-04-13 01:11:12 -0500 | Rating Details | |
2023-04-12 23:21:20 -0500 | Rating Details | |
2023-04-12 21:32:34 -0500 | Rating Details | |
2023-04-12 19:33:31 -0500 | Rating Details | |
2023-04-12 19:26:24 -0500 | Rating Details | |
2023-04-12 17:55:53 -0500 | Rating Details | |
2023-04-12 17:39:04 -0500 | Rating Details | |
2023-04-12 16:51:31 -0500 | Rating Details | |
2023-04-12 16:32:52 -0500 | Rating Details | |
2023-04-12 16:32:26 -0500 | Rating Details | |
2023-04-12 16:05:11 -0500 | Rating Details | |
2023-04-12 15:38:44 -0500 | Rating Details | |
2023-04-12 15:26:36 -0500 | Rating Details | |
2023-04-12 15:22:51 -0500 | Rating Details | |
2023-04-12 15:11:19 -0500 | Rating Details | |
2023-05-06 12:22:41 -0500 | Rating Details | |
2023-05-19 18:48:59 -0500 | Rating Details | |
2023-04-17 02:44:41 -0500 | Rating Details | |
2023-04-16 13:22:18 -0500 | Rating Details | |
2023-04-14 14:04:15 -0500 | Rating Details | |
2023-04-15 16:32:17 -0500 | Rating Details | |
2023-04-17 20:18:21 -0500 | Rating Details | |
2023-04-19 19:04:22 -0500 | Rating Details | |
2023-04-18 18:44:49 -0500 | Rating Details | |
2023-04-15 04:08:47 -0500 | Rating Details | |
2023-04-15 18:30:34 -0500 | Rating Details | |
2023-04-21 01:43:47 -0500 | Rating Details | |
2023-04-17 02:44:41 -0500 | Rating Details | |
2023-04-12 15:22:51 -0500 | Rating Details | |
2023-04-13 13:13:53 -0500 | Rating Details | |
2023-04-12 23:21:20 -0500 | Rating Details | |
2023-04-12 16:05:11 -0500 | Rating Details | |
2023-04-13 13:20:17 -0500 | Rating Details | |
2023-04-12 16:32:52 -0500 | Rating Details | |
2023-04-16 13:22:18 -0500 | Rating Details | |
2023-04-13 02:31:36 -0500 | Rating Details | |
2023-05-19 18:48:59 -0500 | Rating Details | |
2023-04-12 15:26:36 -0500 | Rating Details | |
2023-04-13 03:51:45 -0500 | Rating Details | |
2023-04-14 14:04:15 -0500 | Rating Details | |
2023-04-15 16:32:17 -0500 | Rating Details | |
2023-04-13 01:11:12 -0500 | Rating Details | |
2023-04-13 09:49:21 -0500 | Rating Details | |
2023-04-17 20:18:21 -0500 | Rating Details | |
2023-04-13 04:25:35 -0500 | Rating Details | |
2023-05-06 12:22:41 -0500 | Rating Details | |
2023-04-12 15:11:19 -0500 | Rating Details | |
2023-04-19 19:04:22 -0500 | Rating Details | |
2023-04-13 17:42:52 -0500 | Rating Details | |
2023-04-12 19:33:31 -0500 | Rating Details | |
2023-04-13 01:21:49 -0500 | Rating Details | |
2023-04-18 18:44:49 -0500 | Rating Details | |
2023-04-12 17:55:53 -0500 | Rating Details | |
2023-04-15 04:08:47 -0500 | Rating Details | |
2023-04-12 19:26:24 -0500 | Rating Details | |
2023-04-12 17:39:04 -0500 | Rating Details | |
2023-04-13 10:59:02 -0500 | Rating Details | |
2023-04-12 16:32:26 -0500 | Rating Details | |
2023-04-15 18:30:34 -0500 | Rating Details | |
2023-04-13 09:54:59 -0500 | Rating Details | |
2023-04-21 01:43:47 -0500 | Rating Details | |
2023-04-12 15:38:44 -0500 | Rating Details | |
2023-04-13 14:58:52 -0500 | Rating Details | |
2023-04-12 21:32:34 -0500 | Rating Details | |
2023-04-12 16:51:31 -0500 | Rating Details | |
2023-07-08 01:01:30 -0500 | Rating Details |